Generation Bio Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Generation Bio is a biotechnology company based in Cambridge, Massachusetts, operating from 301 Binney Street, 4th Floor. It works on T cell-driven autoimmune diseases and is developing a ctLNP-based modality to deliver siRNA in vivo to modulate T cell activity that drives inflammation and auto-reactive tissue destruction. The company's workforce falls in the 11-50 employee range and it operates within the Biotechnology Research industry. Publicly available information indicates that Generation Bio Co. was acquired by XOMA Corporation in February 2026. The company maintains a website at https://generationbio.com.